[{"NetIncomeLoss_1_Q3_USD":148234000.0,"GoodwillForeignCurrencyTranslationGainLoss_3_Q3_USD":17081000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-27428000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-72134000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":1097000.0,"PaymentsToAcquireInvestments_3_Q3_USD":1661750000.0,"Depreciation_3_Q3_USD":14076000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-1080889000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q3_USD":3436000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_3_Q3_USD":10106000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-187801000.0,"DerivativeLiabilitiesCurrent_0_Q3_USD":8364000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":27788000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":302071000.0,"EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0_Q3_USD":4500000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":172424000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":10186000.0,"RepaymentsOfSecuredDebt_3_Q3_USD":25040000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":575000000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":21778000.0,"AssetsCurrent_0_Q3_USD":2555573000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3_Q3_shares":660000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":23992000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":43610000.0,"DeferredIncomeTaxAssetsNet_0_Q3_USD":254810000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":252198000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":130717000.0,"ShareBasedCompensation_3_Q3_USD":89614000.0,"Assets_0_Q3_USD":6291958000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":1916942000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":46278000.0,"OperatingLeaseLiability_0_Q3_USD":155003000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":21619000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_1_Q3_USD":26920000.0,"AllocatedShareBasedCompensationExpenseNetOfTax_3_Q3_USD":79508000.0,"ContractWithCustomerLiability_0_Q3_USD":6041000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":207255000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":607061000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-12672000.0,"LongTermDebtCurrent_0_Q3_USD":243999000.0,"LongTermDebt_0_Q3_USD":2087684000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":691000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":10088000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":33254000.0,"Investments_0_Q3_USD":1175000000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":34339000.0,"DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_0_Q3_USD":4079000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":500000000.0,"CommonStockValue_0_Q3_USD":6000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":19283000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":22750000.0,"AccountsReceivableNetCurrent_0_Q3_USD":361664000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-5089000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":26510000.0,"PrepaidExpenseCurrent_0_Q3_USD":58305000.0,"ProceedsFromLinesOfCredit_3_Q3_USD":500000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":56236000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-85000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":219309000.0,"RepaymentsOfConvertibleDebt_3_Q3_USD":356188000.0,"EarningsPerShareBasic_1_Q3_USD":2.67,"EarningsPerShareBasic_3_Q3_USD":1.89,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":1099135000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":198613000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-13941000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":4812000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":56297000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":64902000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q3_USD":3340242000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-639000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2537989000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":920000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":141925000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":741942000.0,"OtherAssetsNoncurrent_0_Q3_USD":38646000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":66684000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":192505000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":20645000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":76890000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-2235000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":196542000.0,"IncreaseDecreaseInInventories_3_Q3_USD":21861000.0,"OtherAssetsCurrent_0_Q3_USD":127258000.0,"CostsAndExpenses_1_Q3_USD":404681000.0,"CostsAndExpenses_3_Q3_USD":1493391000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":472195000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":78647000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":243676000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.115,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.175,"ComprehensiveIncomeNetOfTax_3_Q3_USD":140794000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":600888000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1698050000.0,"OperatingIncomeLoss_3_Q3_USD":204659000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_1_Q3_USD":10000000.0,"ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_3_Q3_USD":215250000.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":17338000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":713377000.0,"DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_0_Q3_USD":8364000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":47139000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":37879000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":30307000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":15760000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":55637000.0,"Goodwill_0_Q3_USD":937099000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":8347000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":48308000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":35592000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":63165000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":172424000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-623000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-2338000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":3540000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":172424000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":0.0,"EarningsPerShareDiluted_1_Q3_USD":2.64,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":55545000.0,"LiabilitiesCurrent_0_Q3_USD":642133000.0,"NetIncomeLoss_3_Q3_USD":105202000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":128204000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_1_Q3_USD":167000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_3_Q3_USD":-327000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":141588000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":33387000.0,"OperatingLeasePayments_3_Q3_USD":16915000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":2241107000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":21618000.0,"PaymentsToAcquireIntangibleAssets_3_Q3_USD":113000000.0,"ShortTermLeaseCost_3_Q3_USD":2702000.0,"SubleaseIncome_1_Q3_USD":0.0,"SubleaseIncome_3_Q3_USD":224000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.053,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":2241107000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":24868000.0,"LongTermDebtNoncurrent_0_Q3_USD":1843685000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":741942000.0,"AccountsPayableCurrent_0_Q3_USD":67063000.0,"ShortTermLeaseCost_1_Q3_USD":942000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-3540000.0,"EarningsPerShareDiluted_3_Q3_USD":1.87,"UnrecordedUnconditionalPurchaseObligationDueInNextRollingTwelveMonths_0_Q3_USD":75400000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":89614000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":517494000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":6291958000.0,"OperatingLeaseCost_1_Q3_USD":5501000.0,"OperatingLeaseCost_3_Q3_USD":16201000.0,"ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_3_Q3_USD":-2228000.0,"DeferredIncomeTaxExpenseBenefit_3_Q3_USD":-120909000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":3340242000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":3090000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":30356000.0,"InvestmentIncomeInterest_1_Q3_USD":2100000.0,"InventoryNet_0_Q3_USD":91404000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_3_Q3_USD":15089000.0,"OciBeforeReclassificationsNetOfTaxAttributableToParent_3_Q3_USD":33364000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q3_USD":1169000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3_Q3_USD":-2287000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":146537000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q3_USD":168140000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3_Q3_USD":130290000.0,"OperatingIncomeLoss_1_Q3_USD":196207000.0,"InvestmentIncomeInterest_3_Q3_USD":9700000.0,"ProceedsFromConvertibleDebt_3_Q3_USD":981381000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":191369000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":13078000.0,"AssetImpairmentCharges_1_Q3_USD":0.0,"AssetImpairmentCharges_3_Q3_USD":136139000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":5004000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":104598000.0,"LeaseCost_1_Q3_USD":6444000.0,"LeaseCost_3_Q3_USD":18681000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":1026480000.0,"VariableLeaseCost_1_Q3_USD":1000.0,"VariableLeaseCost_3_Q3_USD":2000.0,"DeferredFinanceCostsNoncurrentNet_0_Q3_USD":5802000.0,"TaxesPayableCurrent_0_Q3_USD":25910000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":1916942000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":2386426000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":10889000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":2951000.0,"AccruedMarketingCostsCurrent_0_Q3_USD":7721000.0,"StockholdersEquity_0_Q3_USD":3377201000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":142475000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1034000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":66819000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":40613000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":8430000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]